Literature DB >> 7512891

Sensitive method for measuring apoptosis and cell surface phenotype in human thymocytes by flow cytometry.

I Schmid1, C H Uittenbogaart, J V Giorgi.   

Abstract

A rapid, gentle, and sensitive method for quantification of cells undergoing apoptosis is presented. The method allows the simultaneous determination of dual-color cell surface immunofluorescence. Cells are stained for 7 min with the vital dye Hoechst 33342 (HO342) for identification of live and apoptotic cells. 7-amino-actinomycin D (7-AAD) is added to distinguish cells that have lost membrane integrity from apoptotic and live cells. Due to its spectral properties 7-AAD can be utilized on cells that are dual-surface labelled with fluorescein-isothiocyanate (FITC) and phycoerythrin (PE). The value of the method is demonstrated on human thymocytes, which constitutively undergo programmed cell death and which show an increase in the rate of apoptosis after exposure to the glucocorticoid dexamethasone (DEX). Vital staining with HO342 permits earlier detection of apoptotic changes compared to a staining technique in which cells are treated with a hypotonic citrate solution containing propidium iodide (PI) and the apoptotic cells are represented in a hypodiploid, "sub-G1" peak. The HO342/7-AAD method may be particularly applicable to studies of programmed cell death in cells in which DNA fragmentation is difficult to detect by decreased DNA stainability.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7512891     DOI: 10.1002/cyto.990150104

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  44 in total

1.  Suppression of E1A-mediated transformation by the p50E4F transcription factor.

Authors:  E R Fernandes; R J Rooney
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

2.  SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival.

Authors:  Q Liu; T Sasaki; I Kozieradzki; A Wakeham; A Itie; D J Dumont; J M Penninger
Journal:  Genes Dev       Date:  1999-04-01       Impact factor: 11.361

3.  CD31, a Valuable Marker to Identify Early and Late Stages of T Cell Differentiation in the Human Thymus.

Authors:  Marc Douaisi; Rachel S Resop; Maho Nagasawa; Joshua Craft; Beth D Jamieson; Bianca Blom; Christel H Uittenbogaart
Journal:  J Immunol       Date:  2017-02-03       Impact factor: 5.422

4.  Kinetics of Fas-induced apoptosis in thymic organ culture.

Authors:  T Zhou; M Fleck; U Müeller-Ladner; P Yang; Z Wang; S Gay; S Matsumoto; J D Mountz
Journal:  J Clin Immunol       Date:  1997-01       Impact factor: 8.317

5.  Sphingosine-1-phosphate/sphingosine-1-phosphate receptor 1 signaling is required for migration of naive human T cells from the thymus to the periphery.

Authors:  Rachel S Resop; Marc Douaisi; Joshua Craft; Loes C M Jachimowski; Bianca Blom; Christel H Uittenbogaart
Journal:  J Allergy Clin Immunol       Date:  2016-04-04       Impact factor: 10.793

Review 6.  Uses of flow cytometry in virology.

Authors:  J J McSharry
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

7.  Farnesyltransferase inhibitors induce dramatic morphological changes of KNRK cells that are blocked by microtubule interfering agents.

Authors:  N Suzuki; K Del Villar; F Tamanoi
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

8.  Monocytes are required to prime peripheral blood T cells to undergo apoptosis.

Authors:  M X Wu; J F Daley; R A Rasmussen; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

9.  Actinobacillus actinomycetemcomitans leukotoxin induces apoptosis in HL-60 cells.

Authors:  J Korostoff; J F Wang; I Kieba; M Miller; B J Shenker; E T Lally
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

10.  Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro.

Authors:  C A Spina; J C Guatelli; D D Richman
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.